← Open Payments lookup

ANALIZA GUERRERO: Open Payments

NPI 1972821064 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$811 in 34 payments from 11 companies in 2025. Trend: 2023 $953 · 2024 $598 · 2025 $811

Food & beverage: $811
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$313
AKEBIA THERAPEUTICS INC4$85
ANI Pharmaceuticals, Inc.4$84
Novo Nordisk Inc2$67
Bayer Healthcare Pharmaceuticals Inc.3$55
Vifor Pharma, Inc.2$47
Otsuka America Pharmaceutical, Inc.2$42
Ardelyx, Inc.1$34
Calliditas Therapeutics US Inc.1$33
Aurinia Pharma U.S., Inc.1$26

Products named: Vanrafia, Fabhalta, Vafseo, PURIFIED CORTROPHIN GEL, Kerendia, Veltassa, JYNARQUE, IBSRELA.

Industry payments across PA — which companies pay providers there.